PL354044A1 - Bicykliczni agoniści wazopresynyBicykliczni agoniści wazopresyny - Google Patents

Bicykliczni agoniści wazopresynyBicykliczni agoniści wazopresyny

Info

Publication number
PL354044A1
PL354044A1 PL00354044A PL35404400A PL354044A1 PL 354044 A1 PL354044 A1 PL 354044A1 PL 00354044 A PL00354044 A PL 00354044A PL 35404400 A PL35404400 A PL 35404400A PL 354044 A1 PL354044 A1 PL 354044A1
Authority
PL
Poland
Prior art keywords
alkyl
bicyclic
vasopressin agonists
agonists
independently
Prior art date
Application number
PL00354044A
Other languages
English (en)
Other versions
PL206211B1 (pl
Inventor
Doreen M.Ashworth Doreen M. Ashworth
Gary R.W.Pitt Gary R.W. Pitt
PeterHudson Peter Hudson
Christopher M.Yea Christopher M. Yea
Richard J.Franklin Richard J. Franklin
Original Assignee
Ferring Bvferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bvferring Bv filed Critical Ferring Bvferring Bv
Publication of PL354044A1 publication Critical patent/PL354044A1/pl
Publication of PL206211B1 publication Critical patent/PL206211B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL354044A 1999-10-20 2000-10-20 N-acylowe pochodne tetrahydroazepiny, kompozycja farmaceutyczna i zastosowanie tych pochodnych PL206211B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9924836A GB2355454A (en) 1999-10-20 1999-10-20 Antidiuretic agents
PCT/GB2000/004055 WO2001029005A1 (en) 1999-10-20 2000-10-20 Bicyclic vasopressin agonists

Publications (2)

Publication Number Publication Date
PL354044A1 true PL354044A1 (pl) 2003-12-15
PL206211B1 PL206211B1 (pl) 2010-07-30

Family

ID=10863070

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354044A PL206211B1 (pl) 1999-10-20 2000-10-20 N-acylowe pochodne tetrahydroazepiny, kompozycja farmaceutyczna i zastosowanie tych pochodnych

Country Status (22)

Country Link
US (1) US6664249B1 (pl)
EP (1) EP1226122B1 (pl)
JP (1) JP4694747B2 (pl)
KR (1) KR100725555B1 (pl)
CN (1) CN1144788C (pl)
AT (1) ATE284871T1 (pl)
AU (1) AU777092B2 (pl)
CA (1) CA2387886A1 (pl)
CZ (1) CZ304069B6 (pl)
DE (1) DE60016786T2 (pl)
ES (1) ES2234684T3 (pl)
GB (1) GB2355454A (pl)
HK (1) HK1044155B (pl)
HU (1) HU229357B1 (pl)
IL (2) IL148548A0 (pl)
MX (1) MXPA02003779A (pl)
NO (1) NO322920B1 (pl)
NZ (1) NZ517611A (pl)
PL (1) PL206211B1 (pl)
PT (1) PT1226122E (pl)
RU (1) RU2254332C2 (pl)
WO (1) WO2001029005A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
EP1632494A1 (en) * 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
CN102295636A (zh) * 2005-07-29 2011-12-28 弗·哈夫曼-拉罗切有限公司 吲哚-3-基-羰基-哌啶和哌嗪衍生物
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
RU2342949C1 (ru) * 2007-03-26 2009-01-10 Юрий Георгиевич Жуковский Применение [дезамино-1, изолейцин-3, аргинин-8]вазопрессина в качестве средства для увеличения выведения почкой солей натрия и усиления обратного избирательного всасывания из почечных канальцев в кровь воды-растворителя
WO2009021007A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
NO3085381T3 (pl) 2008-05-21 2018-09-15
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
CN102942558B (zh) * 2012-05-18 2014-04-16 天津药物研究院 一种苯并氮杂卓衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0167349B1 (ko) * 1989-10-20 1999-02-18 오스카 아끼히꼬 벤조헤테로 고리 화합물
US5753677A (en) * 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
JP2905909B2 (ja) * 1991-04-19 1999-06-14 大塚製薬株式会社 バソプレシン拮抗剤
TW198715B (pl) * 1991-04-19 1993-01-21 Dtsuka Seiyaku Kk
JPH05320135A (ja) * 1992-05-19 1993-12-03 Yamanouchi Pharmaceut Co Ltd テトラヒドロベンズアゼピン誘導体
TW250481B (pl) 1992-08-20 1995-07-01 Otsuka Pharma Co Ltd
JP2913082B2 (ja) * 1992-10-16 1999-06-28 大塚製薬株式会社 バソプレシン拮抗剤及びオキシトシン拮抗剤
TW270927B (pl) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
AU5533894A (en) 1992-11-25 1994-06-22 Yamanouchi Pharmaceutical Co., Ltd. Benzanilide derivative
WO1994020473A1 (fr) * 1993-03-11 1994-09-15 Yamanouchi Pharmaceutical Co., Ltd. Compose avec action antagoniste de la vasopressine
PL182011B1 (en) * 1993-08-26 2001-10-31 Yamanouchi Pharma Co Ltd Benzazepine derivative, pharmaceutic composition and intermediate compounds
JP2926335B2 (ja) * 1997-06-13 1999-07-28 大塚製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
WO2001029005A1 (en) 2001-04-26
JP4694747B2 (ja) 2011-06-08
US6664249B1 (en) 2003-12-16
CZ20021339A3 (cs) 2002-09-11
HUP0203622A2 (hu) 2003-02-28
ATE284871T1 (de) 2005-01-15
ES2234684T3 (es) 2005-07-01
CZ304069B6 (cs) 2013-09-18
DE60016786D1 (de) 2005-01-20
HU229357B1 (en) 2013-11-28
CN1382125A (zh) 2002-11-27
HUP0203622A3 (en) 2005-01-28
NO20021879D0 (no) 2002-04-19
HK1044155A1 (en) 2002-10-11
AU1037401A (en) 2001-04-30
NZ517611A (en) 2002-11-26
DE60016786T2 (de) 2005-12-22
GB2355454A (en) 2001-04-25
HK1044155B (en) 2005-05-06
PT1226122E (pt) 2005-04-29
KR100725555B1 (ko) 2007-06-08
MXPA02003779A (es) 2002-09-30
CA2387886A1 (en) 2001-04-26
NO322920B1 (no) 2006-12-18
AU777092B2 (en) 2004-09-30
PL206211B1 (pl) 2010-07-30
JP2003512356A (ja) 2003-04-02
EP1226122A1 (en) 2002-07-31
CN1144788C (zh) 2004-04-07
GB9924836D0 (en) 1999-12-22
IL148548A0 (en) 2002-09-12
IL148548A (en) 2007-02-11
EP1226122B1 (en) 2004-12-15
RU2254332C2 (ru) 2005-06-20
NO20021879L (no) 2002-04-19
KR20020029794A (ko) 2002-04-19

Similar Documents

Publication Publication Date Title
ATE135701T1 (de) Imidazolderivate, starke und selektive angiotensin-ii-rezeptor-antagonisten
IL148548A0 (en) Bicyclic vasopressin agonists
CA2288122A1 (en) Neuropeptide y receptor antagonist
CA2037630A1 (en) Nitrogen-containing heterocylic compounds, their production and use
IS6275A (is) Heteróhringa efnasambönd og notkun þeirra sem mótlyf efnaskiptaglútamatviðtaka
CZ305838B6 (cs) N-(2-arylethyl)benzylaminy jako antagonisté receptoru 5-HT6
MY147451A (en) 4-phenyl-pyridine derivatives and their use as nk-1 receptor antagonists
CA2337825A1 (en) Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
EP0287339A3 (en) Piperidine opioid antagonists
MXPA02004448A (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
IL142893A0 (en) Fused polyclic heterocyclic compounds and pharmaceutical compositions containing the same
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
CO5140104A1 (es) Derivados de mevinolina y preparacion farmaceuticas que los contienen
EP0391721A3 (en) Ocular hypotensive agents
CA2134077A1 (en) 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy
HU9801950D0 (en) 2-(arylphenyl)-amino-imidazoline derivatives
HU9801792D0 (en) 4-aminopyrrole(3,2-d)pyrimidines as neuropeptide y receptor antagonists
ATE170851T1 (de) Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten
GB0130868D0 (en) New compounds
TW334428B (en) Novel benzodiazepine derivatives
GB2341799B (en) Medicaments for the treatment of primary headache disorders and drug-induced headaches
WO2002017954A1 (fr) Medicaments contre la maladie de parkinson
PL246418A1 (en) Process for preparing n-/3-trifluoromethylphenyl/-n'-propargylpiperazine
CA2245484A1 (en) Novel urea derivatives
CA2129813A1 (en) 5-aminoflavone derivatives

Legal Events

Date Code Title Description
RECP Rectifications of patent specification